JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Abstract Details

Activity Number: 231
Type: Topic Contributed
Date/Time: Monday, July 30, 2012 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract - #306614
Title: Case Studies of Adaptive Design in Vaccine Clinical Trials
Author(s): Xiaoming Li*+
Companies: Gilead Sciences
Address: , Seattle, WA, 98121, USA
Keywords: Vaccine trial ; adaptive design ; two-stage ; population enrichment

Adaptive design has drawn much attention in clinical trial development in recent years, as another tool for efficient clinical study design. Its application in vaccine development is discussed with two real examples. In the first example of a Phase IV trial, a two-stage adaptive design strategy built on the traditional fixed-number-of-events design was proposed for the scenario in which the primary efficacy endpoint is a (rare) single infection/disease event with unknown incidence rate. In the second example, a population enrichment strategy is proposed for a Phase III vaccine efficacy trial to enable the flexibility allowing pre-specified modifications to an ongoing trial to mitigate the potential risk associated with the efficacy assumptions made for different populations at the design stage. While these approaches were developed in the setting of vaccine efficacy trials, they can be readily applicable in other therapeutic areas.

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2012 program

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.